Andrew Hillman is a business consultant and strategic advisor based in Dallas, Texas, with more than thirty years co-founding, operating, and exiting companies in FDA-regulated healthcare. He is Principal of Hillman Ventures, the Dallas family office he founded in 1995, which invests personal capital in FDA-regulated healthcare and biotechnology. He advises founders, owners, boards, and investors on growth, regulatory strategy, and capital, and the advice reflects work he has been accountable for rather than work he has only observed.
I work as a business consultant and strategic advisor to companies operating under FDA and CMS oversight. In an engagement I go deep on the business. We look at revenue, operations, regulatory pressure, and leadership. The goal is simple. Better decisions. Better outcomes.
You do not get generic advice. You get one view of your situation that connects the business and the rules it has to answer to. What the regulator permits determines what you can sell and when. A growth plan that ignores that is a forecast, not a plan.
When you bring me into an engagement, I am clear about which hat I am wearing and where Hillman Ventures sits in the picture. If I advise you as a consultant, I tell you exactly how any investment interests intersect with the work. If I advise you as an investor, I tell you exactly where my role ends and where your own teams or outside counsel must step in. The point is trust. You get one honest view of the situation, backed by three decades in FDA regulated healthcare and frontier biotech, without hidden agendas.
The companies, the operating history, and the public record are published in full on the sites below. Where a claim can be checked against a primary source, it is.
I work with operators, founders, and investors who run or back healthcare, biotech, and other complex service businesses. If your world is regulated, investor backed, or both, you are in my lane.
On the operator side, that includes clinics, hospitals, diagnostics groups, telehealth and medical adjacent services, and other teams dealing with real patients, real compliance, and real cost pressure. On the founder side, it includes biotech, frontier health, and data driven ventures building products or services that live under FDA, CMS, privacy, or similar oversight.
On the investor side, I work with private investors, family offices, and funds looking at healthcare, biotech, and complex service portfolios. I help you understand how growth plans, regulatory risk, and execution reality line up with your capital decisions. You get a view that respects both the business and the investment thesis.
If you are somewhere in that mix and you want sharper growth, regulatory, or portfolio decisions, you are the audience for my work. I am not the right fit if you want generic motivation or broad, feel good consulting. I build outcomes with people who own serious responsibility and want direct, informed guidance.
New clients start with a short, paid Diagnostic Advisory Engagement. A brief qualifying exchange comes first, so we both know it is the right use of your money.
The Diagnostic Advisory Engagement